Publications
5891 Results
- Journal / Conference
- Cancer Research 72(24 suppl):570S abst. OT2-2-04; San Antonio Breast Cancer Symposium, poster presentation - ongoing trials, (12/4-8/2012, San Antonio, TX);
- Year
- 2012
- Research Committee(s)
- Breast
- Study Number(s)
- S1207
A phase III randomized, placebo-controlled cllinical trial evaluating the use of adjuvant endocrine therapy +/- one year of everolimus in patients with high-risk, hormone receptor-(HR) positive and Her2-neu negative breast cancer: SWOG/NSABP S1207
- Journal / Conference
- Society of Integrative Oncology Annual Meeting (Oct 8-10, 2012, Albuquerque, NM), oral ;
- Year
- 2012
- Research Committee(s)
- Symptom Management and Survivorship
- Study Number(s)
- S1200
Methods for standardizing true and sham acupuncture in a multicenter randomized trial to reduce joint symptoms related to aromatase inhibitors in women with early stage breast cancer (SWOG 1200)
- Journal / Conference
- The Clinical Neuropsychologist 26(5):751-768
- Year
- 2012
- Research Committee(s)
- Prevention, Screening, and and Surveillance
- PMID
- PMID22651854
- PMC
- PMC23064404
- Study Number(s)
- S0000A
Age expanded normative data for the Ruff 2 & 7 Selective Attention Test: evaluating cognition in older males
- Journal / Conference
- Blood 120(21):abst.3584; American Society of Hematology Annual Meeting, poster;
- Year
- 2012
- Research Committee(s)
- Leukemia
- Study Number(s)
- S0703
A phase II trial of azacitidine (NSC-102816) and gemtuzumab ozogamicin (NSC0720568) as induction and post-remission therapy in patients of age 60 and older with previusly untreated non-M3 acute myeloid leukemia (SWOG S0703): Report on the poor risk patients
- Journal / Conference
- Blood 120(21):abst.2603; American Society of Hematology Annual Meeting, poster;
- Year
- 2012
- Research Committee(s)
- Leukemia
- Study Number(s)
- S0910
SWOG study S0910: a phase 2 trial of clofarabine/cytarabine/epratuzumab for relapsed/refractory acute lymphocytic leukemia
- Journal / Conference
- Blood 120(21):abst.2712; American Society of Hematology, poster;
- Year
- 2012
- Research Committee(s)
- Lymphoma
- Study Number(s)
- S0016, SWOG-8947, S9800, S9911
Low serum vitamin D levels are associated with inferior survival in follicular lymphoma: a prospective evaluation and replication in SWOG and LYSA
- Journal / Conference
- Blood 120(21):abst. 2590; American Society of Hematology Annual Meeting, poster;
- Year
- 2012
- Research Committee(s)
- Leukemia
- Study Number(s)
- S0106, SWOG-9031, SWOG-9333, SWOG-9500
A scoring system of prediction of FLT3-ITD positivity in patients with newly diagnosed acute myeloid leukemia: a SWOG, Fred Hutchinson and M.D. Anderson Cancer Center study
- Journal / Conference
- Blood 120(21):abst. 129; American Society of Hematology Annual Meeting, oral;
- Year
- 2012
- Research Committee(s)
- Leukemia
- Study Number(s)
- S0106, S0112, SWOG-8600, SWOG-9031, SWOG-9126, SWOG-9333, SWOG-9500, S9617, S9918
Declining rates of treatment-related mortality recent in patients with newly-diagnosed AML given "intense" induction regimens: a report from SWOG and MD Anderson
- Journal / Conference
- Blood 120(21):abst.2489; American Society of Hematology Annual Meeting, poster;
- Year
- 2012
- Research Committee(s)
- Leukemia
- Study Number(s)
- S0112, S0301, SWOG-9031, SWOG-9333
Single-cell network profiling (SCNP)-based classifier to predict response to induction therapy in elderlly patients with acute myeloid leukemia (AML): validation in two independent sample sets from ECOG and SWOG trials
- Journal / Conference
- Blood 120(21)abst. 540; American Society of Hematology Annual Meeting, oral;
- Year
- 2012
- Research Committee(s)
- Leukemia
- Study Number(s)
- S0106, S0112, SWOG-8600, SWOG-9031, SWOG-9034 (EST-3489) (CALGB-9120), SWOG-9333, SWOG-9500, S9617